查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1998280

横向流动化验市场：依产品类型、检体类型、规格、方法、应用和最终用户划分－2026-2032年全球市场预测

Lateral Flow Assays Market by Product Type, Sample Type, Format, Technique, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，横向流动化验市场价值将达到 111.6 亿美元，到 2026 年将成长至 118.9 亿美元，到 2032 年将达到 178.5 亿美元，复合年增长率为 6.93%。

主要市场统计数据
基准年 2025 111.6亿美元
预计年份：2026年 118.9亿美元
预测年份 2032 178.5亿美元
复合年增长率 (%) 6.93%

本文阐明了横向流动化验在改变照护现场诊断和在新兴医疗环境中实现快速检测方面所发挥的关键作用。

横向流动化验正迅速成为照护现场的核心技术，为医疗机构和商业设施提供快速、经济高效且易于使用的检测平台。该技术最初开发用于妊娠检测，如今已扩展到传染病筛检、药物滥用检测、心臟标记评估和环境监测等领域。其易用性、极低的训练要求和快速出结果的特点使其在包括诊断检查室、医院、居家照护机构和研究机构在内的各种场所中广泛应用。随着全球医疗系统日益重视分散式检查和早期发现，横向流动化验能够提供快速、可操作的结果，以支援及时的临床决策。

重构横向流动化验市场，探索检体分析和检测技术创新的关键变革因素。

在数位创新、先进材料科学和整合互联技术的共同推动下，横向流动化验领域正经历着一场变革。首先，由人工智慧演算法驱动的新一代领先技术的涌现，透过实现自动化影像分析、即时结果解读和基于云端的资料聚合，显着提升了检测效能。同时，新型奈米材料和改进的偶联化学技术的应用，将分析灵敏度提升至与实验室免疫检测相当的水平，并拓展了可检测生物标誌物的范围。

检验2025 年美国关税对横向流动化验供应链、商业策略和全球贸易趋势的多方面影响。

美国于2025年加征关税，对横向流动化验组件和成品的全球贸易趋势产生了重大影响。依赖进口关键耗材（如抗体、硝化纤维素膜和塑胶外壳）的製造商面临投入成本上升的困境，进而影响了其定价策略和利润率。为应对这项挑战，许多供应商加快了供应商网路多元化的步伐，与不同地区的合作伙伴合作，以确保以具有竞争力的价格获得稳定的原材料供应。

透过产品、检体格式、方法、应用和最终用户进行关键細項分析，以提高检测开发中的精确策略。

对于寻求精准成长机会和市场定位的相关人员，深入了解检测市场区隔至关重要。按产品类型分析，试剂盒仍是主要的收入来源，而领先企业正透过增强数位化能力和互联互通来提升市场动能。由于日常检测维护和品管的需要，试剂和耗材的需求保持稳定。从检体类型来看，全血在临床诊断中仍然占据主导地位，但唾液检测日益受到关注，反映出人们对非侵入性检测解决方案的追求。血清和血浆检测是脂质和胆固醇检测的基础，而尿液检查在药物滥用检测和感染疾病监测中继续发挥至关重要的作用。

分析美洲、欧洲、中东和非洲以及亚太地区在需求、技术采用和法规环境的区域差异。

区域趋势在塑造横向流动化验市场的发展轨迹中发挥着至关重要的作用。在美洲，完善的医疗基础设施和积极主动的监管机构正在推动创新照护现场技术的快速普及。公共卫生倡议和报销机制持续奖励分散式检查的发展，从而支持在当地诊所和零售医疗中心的广泛部署。同样，跨境贸易协定也促进了检测组件的流通，并加强了北美和拉丁美洲之间的合作研究网络。

主要企业的关键策略倡议、竞争定位和合作伙伴关係正在塑造横向流动化验市场的未来前景。

横向流动化验领域的竞争格局呈现出多元化的特点，既有成熟的诊断领导企业，也有专业的试剂供应商和敏捷的Start-Ups。大型诊断公司正利用其广泛的分销网络，推出先进的领先系统和整合连接功能的多重检测板，以增强其传统的试剂盒产品线。同时，专业的试剂製造商致力于提高抗体特异性和膜技术，以帮助终端用户获得更高的分析性能。Start-Ups和利基市场参与者则透过引领新型标记剂（例如上转换磷光体和量子点）的开发，拓展可侦测标靶的范围，进而推动市场动态的发展。

为产业领导者提供切实可行的策略建议，以推动成长、优化横向流动化验操作并抓住新机会。

为了在不断变化的横向流动化验市场中脱颖而出，并确保竞争优势，产业领导者应优先采取一系列策略行动。首先，投资领先的数位技术和数据分析平台，可以开拓远端监测、病人参与和即时流行病学洞察等新机会。其次，透过近岸外包和多区域布局实现製造地多元化，可以降低关税风险，并增强供应链韧性。第三，与抗体和膜材料创新者建立合作关係，可以加速研发进度，并提升独特的检测能力。

概述一种结合定性和定量方法的综合调查方法：专家访谈和资料三角验证，以确保分析的严谨性。

本分析所依据的研究采用了一套严谨的多阶段方法，旨在兼顾广度和深度。首先，研究人员透过对50多位产业专家进行深入访谈，收集了第一手质性资料。这些专家包括研发负责人、监管专家、采购经理和终端用户代表。访谈内容涵盖了技术趋势、市场驱动因素和挑战以及营运问题等诸多方面，提供了细緻入微的观点。同时，研究人员也进行了二次调查，全面查阅了同行评审期刊、监管出版刊物、专利申请和技术白皮书，从而对定量市场指标和定性研究结果进行了三角检验。

结论：重点阐述了动态横向流动化验趋势中相关人员面临的策略挑战、创新路径和成长前景。

总之，横向流动化验在快速诊断创新领域中处于领先地位，这得益于材料科学、数位化整合和多重测量能力的进步。 2025年关税的实施加速了供应链多元化、离岸生产和采购优化，凸显了敏捷性和韧性的重要性。详细的细分市场分析揭示了不同产品类型、检体基质、检测形式和应用领域的成长轨迹，而区域洞察则突显了美洲、欧洲、中东和非洲以及亚太市场的战略特征。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章横向流动化验市场：依产品类型划分

  • 成套工具
  • 领导者
  • 试剂和耗材

第九章检体类型横向流动化验市场

  • 唾液
  • 血清/血浆
  • 尿
  • 全血

第十章：横向流动化验市场：依形式划分

  • 磁带
  • 条
  • 孔盘

第十一章横向流动化验市场：依技术划分

  • 竞争性检测
  • 多重侦测
  • 三明治法

第十二章横向流动化验市场：依应用领域划分

  • 临床诊断
    • 心臟标记检测
    • 药物滥用检测
    • 感染疾病
    • 血脂和胆固醇检测
    • 妊娠和不孕症检查
  • 环境测试
  • 食品安全
  • 品管
  • 兽医检查

第十三章横向流动化验市场：依最终用户划分

  • 诊断检查室
  • 居家照护
  • 医院和诊所
  • 即时检测
  • 研究机构

第十四章横向流动化验市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章横向流动化验市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章横向流动化验市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章：美国横向流动化验市场

第十八章：中国横向流动化验市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Abcam PLC by Danaher Corporation
  • BBI Solutions
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • BioFluidix GmbH by Hamilton Company
  • BioMerieux SA
  • BioPorto Diagnostics A/S
  • Cytodiagnostics Inc.
  • Danaher Corporation
  • Elabscience Bionovation Inc.
  • F. Hoffmann-La Roche Ltd.
  • Fortis Life Sciences
  • Hologic, Inc.
  • Leinco Technologies, Inc.
  • Merck KGaA
  • Microcoat Biotechnologie GmbH
  • Milenia Biotec GmbH
  • PerkinElmer Inc.
  • Porex Corporation by Filtration Group Corporation
  • QIAGEN NV
  • QuidelOrtho Corporation
  • R-Biopharm AG
  • Rockland Immunochemicals, Inc.
  • Shenzhen SEKBIO Co., Ltd.
  • Siemens Healthineers AG
  • Suzhou Vdo Biotech Co.,Ltd.
  • Tetracore, Inc.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-DD6333AE5DFB

The Lateral Flow Assays Market was valued at USD 11.16 billion in 2025 and is projected to grow to USD 11.89 billion in 2026, with a CAGR of 6.93%, reaching USD 17.85 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 11.16 billion
Estimated Year [2026] USD 11.89 billion
Forecast Year [2032] USD 17.85 billion
CAGR (%) 6.93%

Unveiling the Critical Role of Lateral Flow Assays in Revolutionizing Point-of-Care Diagnostics and Enabling Rapid Testing Across Emerging Healthcare Settings

Lateral flow assays have rapidly emerged as a cornerstone technology in point-of-care diagnostics, offering a versatile platform for rapid, low-cost, and user-friendly testing across healthcare and commercial settings. Originally developed for pregnancy testing, these assays have expanded into infectious disease screening, drug abuse detection, cardiac marker evaluation, and environmental monitoring. Their ease of use, combined with minimal training requirements and rapid time to result, has driven widespread adoption by diagnostic laboratories, hospitals, home care providers, and research institutes alike. As healthcare systems worldwide place greater emphasis on decentralized testing and early detection, lateral flow assays deliver quick actionable results that support timely clinical decision-making.

Moreover, ongoing innovations in assay chemistry, reader integration, and sample preparation techniques have significantly enhanced sensitivity and specificity. The integration of smartphone-based readers and portable devices has further democratized access to diagnostic data, enabling remote healthcare delivery and telemedicine applications. Consequently, market stakeholders are increasingly focusing on next-generation assay formats, multiplexing capabilities, and connectivity solutions. In parallel, regulatory bodies are streamlining approval pathways and establishing quality requirements that ensure robust performance standards. This convergence of technological advancement, regulatory evolution, and growing demand for decentralized testing creates a dynamic landscape in which lateral flow assays continue to redefine rapid diagnostics.

Exploring the Key Transformational Forces Reshaping the Lateral Flow Assay Market and Driving Innovation in Sample Analysis and Detection Technologies

The landscape of lateral flow assays is undergoing transformative shifts driven by the convergence of digital innovation, advanced materials science, and integrated connectivity. First, the emergence of next-generation readers equipped with artificial intelligence algorithms is elevating assay performance by enabling automated image analysis, real-time result interpretation, and cloud-based data aggregation. In tandem, the adoption of novel nanomaterials and enhanced conjugate chemistries is pushing analytical sensitivity to rival laboratory-based immunoassays, thereby broadening the spectrum of detectable biomarkers.

Furthermore, the integration of smartphone applications and Internet of Things connectivity is empowering end users with seamless data sharing, remote monitoring, and epidemiological tracking. These digital tools facilitate longitudinal patient management, outbreak surveillance, and supply chain optimization. Simultaneously, the rise of multiplex assay platforms allows simultaneous detection of multiple analytes within a single test, driving operational efficiency and reducing sample volume requirements. Additionally, tailored assay formats such as cassette, strip, and well plate configurations are aligning with diverse workflow needs-from field testing in environmental and food safety settings to high-throughput screening in clinical laboratories.

Collectively, these technological and operational advances are fostering a more agile, interconnected, and responsive ecosystem for lateral flow diagnostics. As a result, stakeholders are positioned to capitalize on emerging opportunities in personalized medicine, telehealth, and decentralized care models, setting the stage for sustained innovation and market expansion.

Examining the Multifaceted Impact of 2025 United States Tariffs on Lateral Flow Assay Supply Chains Commercial Strategies and Global Trade Dynamics

The implementation of tariffs by the United States in 2025 has markedly influenced the global trade dynamics of lateral flow assay components and finished devices. Manufacturers reliant on imports of critical consumables, including antibodies, nitrocellulose membranes, and plastic housing, confronted elevated input costs that reverberated through pricing strategies and profit margins. In response, many suppliers expedited efforts to diversify their vendor networks, engaging with partners across alternative regions to secure stable material supply at competitive rates.

Moreover, the cost pressures induced by tariff escalation prompted end users to reevaluate inventory management practices and procurement cycles. Diagnostic laboratories and point-of-care providers sought to consolidate orders, pursue volume discounts, and negotiate long-term agreements to mitigate the impact of fluctuating import duties. Concurrently, leading assay developers intensified in-country manufacturing initiatives and strategic partnerships with local producers, thereby reducing exposure to cross-border levies and strengthening supply chain resilience.

These realignments have stimulated investment in nearshore manufacturing facilities and automation technologies that lower dependency on volatile trade routes. At the same time, regulatory agencies have adjusted compliance frameworks to facilitate rapid registration of domestically produced assay kits. Through these collective measures, the industry continues to adapt to tariff-driven challenges while preserving the accessibility and affordability of lateral flow diagnostics on a global scale.

Deciphering Core Segmentation Insights by Product Sample Format Technique Application and End User to Enhance Precision Strategies in Assay Development

A nuanced understanding of assay market segmentation is critical for stakeholders seeking targeted growth opportunities and precision positioning. When analyzed by product type, kits remain the primary revenue driver, while readers gain traction through digital enhancements and connectivity features, and reagents and consumables maintain steady demand due to routine assay maintenance and quality control needs. Shifting attention to sample type reveals that whole blood continues to dominate clinical diagnostics, but emerging interest in saliva-based assays reflects the pursuit of noninvasive testing solutions. Serum and plasma applications underpin lipid and cholesterol panels, whereas urine screening remains essential for drug abuse testing and infectious disease surveillance.

Format selection also influences market pathways: cassette configurations appeal to home care and point-of-care testing environments for their user-friendly design, strip formats support high-volume clinical settings through streamlined workflows, and well plate layouts integrate seamlessly into automated laboratory platforms. Across assay techniques, sandwich immunoassays hold prominence in infectious disease detection, competitive assays serve small-molecule screening needs, and multiplex platforms address simultaneous biomarker analysis for comprehensive diagnostic insights. Application segmentation underscores the versatility of lateral flow assays, with environmental testing detecting waterborne contaminants, food safety monitoring ensuring supply chain integrity, veterinary testing bolstering animal health surveillance, and quality control checks safeguarding manufacturing processes. Clinical diagnostics remains the largest application arena, driven by subsegments such as cardiac marker evaluation, drug abuse panels, infectious disease screening, lipid profiling, and fertility assessments. Finally, end users span diagnostic laboratories, hospitals and clinics, research institutes, home care providers, and point-of-care testing facilities.

By mapping these dimensions, organizations can refine product development, prioritize market entry efforts, and tailor marketing strategies to address the distinct requirements of each segment.

Analyzing Regional Variations in Demand Technological Adoption and Regulatory Environments Across the Americas Europe Middle East Africa and Asia-Pacific

Regional dynamics play a pivotal role in shaping the lateral flow assay market's trajectory. In the Americas, robust healthcare infrastructure and proactive regulatory agencies have fostered rapid adoption of innovative point-of-care diagnostics. Public health initiatives and reimbursement frameworks continue to incentivize decentralized testing, supporting widespread deployment in community clinics and retail health centers. Cross-border trade agreements have similarly facilitated the flow of assay components and enhanced collaborative research networks across North and Latin America.

Turning to Europe, the Middle East, and Africa, market growth exhibits notable heterogeneity driven by diverse healthcare expenditure levels and regulatory landscapes. While Western European nations integrate digital readout devices into standardized care pathways, emerging economies in the Middle East and Africa prioritize low-cost, easy-to-use assays for infectious disease monitoring and maternal health programs. Harmonized approval processes within regional economic communities streamline product registration, yet localized certification requirements necessitate tailored market entry tactics.

In the Asia-Pacific region, manufacturing capabilities and government modernization programs have positioned several countries as leading production hubs for lateral flow devices. National health campaigns and pandemic preparedness initiatives have further accelerated uptake of rapid diagnostics in China, India, Japan, and Southeast Asia. Incentives for domestic innovation, coupled with strategic export policies, enable manufacturers to scale operations and serve both local and international demand. These regional distinctions underscore the need for customized strategies that address regulatory complexity, distribution infrastructure, and evolving end-user preferences.

Highlighting Strategic Moves Competitive Positioning and Collaborative Partnerships of Leading Companies Shaping the Future of the Lateral Flow Assay Market

The competitive landscape of lateral flow assays is defined by a mix of established diagnostics leaders, specialized reagent suppliers, and agile startups. Leading diagnostics corporations have leveraged their extensive distribution networks to introduce advanced reader systems and multiplex panels, integrating connectivity features that augment their traditional kit portfolios. In parallel, dedicated reagent manufacturers focus on refining antibody specificity and membrane technologies, enabling end-users to achieve higher analytical performance. Startups and niche players contribute to market dynamism by pioneering novel labeling agents such as up-converting phosphors and quantum dots, expanding the range of detectable targets.

Collaborative partnerships have become a strategic imperative, with cross-industry alliances bridging diagnostics firms, academic institutions, and technology providers. These collaborations accelerate product development cycles, facilitate knowledge transfer, and support co-development of integrated hardware-software solutions. Moreover, mergers and acquisitions serve as a conduit for portfolio expansion, allowing companies to integrate complementary assay formats and diversify application coverage. Licensing agreements further enable early-stage innovators to scale manufacturing and distribution, while multi-stakeholder consortia drive standardization efforts and regulatory harmonization.

As a result, market leaders that align R&D investments with customer-centric offerings, forge strategic alliances, and maintain agile supply chains will be best positioned to capture growth, respond to emerging health threats, and set new performance benchmarks.

Presenting Actionable Strategic Recommendations for Industry Leaders to Drive Growth Optimize Operations and Leverage Emerging Opportunities in Lateral Flow Assays

To navigate the evolving lateral flow assay marketplace and secure a competitive edge, industry leaders should prioritize a series of strategic actions. First, investing in digital reader technologies and data analytics platforms will unlock new opportunities for remote monitoring, patient engagement, and real-time epidemiological insights. Secondly, diversifying manufacturing footprints through nearshoring or multi-region facilities mitigates tariff risks and enhances supply chain resiliency. Third, fostering collaborative partnerships with antibody and membrane material innovators accelerates development timelines and strengthens proprietary assay performance.

In addition, firms should explore multiplexing capabilities to address growing demand for comprehensive biomarker panels that streamline workflows and reduce per-test costs. Targeted expansion into emerging markets in Africa and Southeast Asia requires engagement with local stakeholders, adaptation to regional regulatory frameworks, and development of cost-effective assay formats. Strengthening post-market surveillance and quality management processes will ensure compliance and build customer trust. Finally, aligning commercial strategies with personalized medicine trends-such as companion diagnostics for targeted therapies-can open new revenue streams and reinforce long-term relevance.

By implementing these recommendations in a coordinated manner, organizations can drive sustainable growth, foster innovation synergies, and deliver high-impact solutions that meet the evolving needs of healthcare providers and end users.

Outlining a Comprehensive Research Methodology Combining Qualitative and Quantitative Approaches Expert Interviews and Data Triangulation to Ensure Analytical Rigor

The research underpinning this analysis employs a rigorous, multi-stage methodology designed to ensure both breadth and depth of insight. Initially, primary qualitative data were collected through in-depth interviews with more than fifty industry experts, including R&D heads, regulatory specialists, procurement managers, and end-user representatives. These interviews provided nuanced perspectives on technological trends, market drivers, and operational challenges. In parallel, secondary research encompassed a comprehensive review of peer-reviewed journals, regulatory agency publications, patent filings, and technical whitepapers, enabling triangulation of quantitative market indicators and qualitative findings.

Subsequently, a structured data-triangulation approach synthesized information across multiple sources to validate key trends and corroborate expert viewpoints. The research team mapped segmentation dimensions-product type, sample type, format, technique, application, and end user-and cross-referenced these with regional, competitive, and policy dynamics. Advanced analytical tools facilitated scenario analysis, competitive benchmarking, and supply chain modeling, ensuring robust interpretations of tariff impacts and strategic implications.

Throughout the process, the methodology adhered to stringent quality protocols, including peer reviews, data validation checks, and iterative feedback loops with subject matter experts. This comprehensive framework delivers a dependable foundation for strategic decision-making and offers stakeholders clarity on the complex factors shaping the lateral flow assay market.

Concluding Key Takeaways Emphasizing Strategic Imperatives Innovation Pathways and Growth Prospects for Stakeholders in the Dynamic Lateral Flow Assay Landscape

In summary, lateral flow assays stand at the forefront of rapid diagnostic innovation, fueled by advancements in materials science, digital integration, and multiplexing capabilities. The imposition of tariffs in 2025 has catalyzed supply chain diversification, nearshore production, and procurement optimization, underscoring the importance of agility and resilience. Detailed segmentation analysis reveals differentiated growth pathways across product types, sample matrices, assay formats, and application domains, while regional insights highlight the strategic nuances of the Americas, Europe, Middle East, Africa, and Asia-Pacific markets.

Competitive dynamics continue to evolve as established diagnostics firms, specialized reagent developers, and pioneering startups vie for market leadership through strategic partnerships, product innovation, and portfolio expansion. To thrive in this dynamic environment, industry participants must invest in digital readers, fortify supply chains against trade disruptions, and pursue collaborative ventures that accelerate innovation. Customized strategies that address regional regulatory contexts and end-user requirements will be instrumental in capturing growth and delivering high-impact solutions.

By embracing these strategic imperatives and leveraging the insights presented, stakeholders are well positioned to navigate the complexities of the lateral flow assay ecosystem, drive sustainable growth, and enhance patient outcomes through rapid, accurate, and accessible diagnostics.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Lateral Flow Assays Market, by Product Type

  • 8.1. Kits
  • 8.2. Readers
  • 8.3. Reagents & Consumables

9. Lateral Flow Assays Market, by Sample Type

  • 9.1. Saliva
  • 9.2. Serum & Plasma
  • 9.3. Urine
  • 9.4. Whole Blood

10. Lateral Flow Assays Market, by Format

  • 10.1. Cassette
  • 10.2. Strip
  • 10.3. Well Plate

11. Lateral Flow Assays Market, by Technique

  • 11.1. Competitive Assays
  • 11.2. Multiplex Assays
  • 11.3. Sandwich Assays

12. Lateral Flow Assays Market, by Application

  • 12.1. Clinical Diagnostics
    • 12.1.1. Cardiac Marker Testing
    • 12.1.2. Drug of Abuse Testing
    • 12.1.3. Infectious Diseases
    • 12.1.4. Lipid/Cholesterol Testing
    • 12.1.5. Pregnancy & Fertility Testing
  • 12.2. Environmental Testing
  • 12.3. Food Safety
  • 12.4. Quality Control
  • 12.5. Veterinary Testing

13. Lateral Flow Assays Market, by End User

  • 13.1. Diagnostic Laboratories
  • 13.2. Home Care
  • 13.3. Hospitals & Clinics
  • 13.4. Point Of Care Testing
  • 13.5. Research Institutes

14. Lateral Flow Assays Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Lateral Flow Assays Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Lateral Flow Assays Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Lateral Flow Assays Market

18. China Lateral Flow Assays Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abbott Laboratories
  • 19.6. Abcam PLC by Danaher Corporation
  • 19.7. BBI Solutions
  • 19.8. Becton, Dickinson and Company
  • 19.9. Bio-Rad Laboratories, Inc.
  • 19.10. Bio-Techne Corporation
  • 19.11. BioFluidix GmbH by Hamilton Company
  • 19.12. BioMerieux SA
  • 19.13. BioPorto Diagnostics A/S
  • 19.14. Cytodiagnostics Inc.
  • 19.15. Danaher Corporation
  • 19.16. Elabscience Bionovation Inc.
  • 19.17. F. Hoffmann-La Roche Ltd.
  • 19.18. Fortis Life Sciences
  • 19.19. Hologic, Inc.
  • 19.20. Leinco Technologies, Inc.
  • 19.21. Merck KGaA
  • 19.22. Microcoat Biotechnologie GmbH
  • 19.23. Milenia Biotec GmbH
  • 19.24. PerkinElmer Inc.
  • 19.25. Porex Corporation by Filtration Group Corporation
  • 19.26. QIAGEN N.V.
  • 19.27. QuidelOrtho Corporation
  • 19.28. R-Biopharm AG
  • 19.29. Rockland Immunochemicals, Inc.
  • 19.30. Shenzhen SEKBIO Co., Ltd.
  • 19.31. Siemens Healthineers AG
  • 19.32. Suzhou Vdo Biotech Co.,Ltd.
  • 19.33. Tetracore, Inc.
  • 19.34. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL LATERAL FLOW ASSAYS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL LATERAL FLOW ASSAYS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA LATERAL FLOW ASSAYS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY READERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY READERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY READERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY SALIVA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY SALIVA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY SALIVA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY SERUM & PLASMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY SERUM & PLASMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY SERUM & PLASMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY URINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY URINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY URINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY WHOLE BLOOD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY WHOLE BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY CASSETTE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY CASSETTE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY CASSETTE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY STRIP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY STRIP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY STRIP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY WELL PLATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY WELL PLATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY WELL PLATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY COMPETITIVE ASSAYS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY COMPETITIVE ASSAYS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY COMPETITIVE ASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY MULTIPLEX ASSAYS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY MULTIPLEX ASSAYS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY MULTIPLEX ASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY SANDWICH ASSAYS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY SANDWICH ASSAYS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY SANDWICH ASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY CARDIAC MARKER TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY CARDIAC MARKER TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY CARDIAC MARKER TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY DRUG OF ABUSE TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY DRUG OF ABUSE TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY DRUG OF ABUSE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY LIPID/CHOLESTEROL TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY LIPID/CHOLESTEROL TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY LIPID/CHOLESTEROL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY ENVIRONMENTAL TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY ENVIRONMENTAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY ENVIRONMENTAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY FOOD SAFETY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY FOOD SAFETY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY FOOD SAFETY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY QUALITY CONTROL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY QUALITY CONTROL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY QUALITY CONTROL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY VETERINARY TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY VETERINARY TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY VETERINARY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY POINT OF CARE TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY POINT OF CARE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS LATERAL FLOW ASSAYS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. GCC LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. GCC LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. GCC LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. GCC LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 171. GCC LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 172. GCC LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. GCC LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 174. GCC LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. G7 LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. G7 LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. G7 LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. G7 LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 195. G7 LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 196. G7 LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. G7 LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 198. G7 LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. NATO LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 200. NATO LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. NATO LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. NATO LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 203. NATO LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 204. NATO LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. NATO LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 206. NATO LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 209. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. CHINA LATERAL FLOW ASSAYS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 217. CHINA LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. CHINA LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. CHINA LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 220. CHINA LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 221. CHINA LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. CHINA LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 223. CHINA LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)